Literature DB >> 25985200

Psychosocial Interventions for Problem Alcohol Use in Primary Care Settings (PINTA): Baseline Feasibility Data.

Jan Klimas, Anne Marie Henihan, Geoff McCombe, Davina Swan, Rolande Anderson, Gerard Bury, Colum Dunne, Eamon Keenan, Jean Saunders, Gillian Williams Shorter, Bobby P Smyth, Walter Cullen.   

Abstract

OBJECTIVE: Many individuals receiving methadone maintenance receive their treatment through their primary care provider. As many also drink alcohol excessively, there is a need to address alcohol use to improve health outcomes for these individuals. We examined problem alcohol use and its treatment among people attending primary care for methadone maintenance treatment, using baseline data from a feasibility study of an evidence-based complex intervention to improve care.
METHODS: Data on addiction care processes were collected by (1) reviewing clinical records (n = 129) of people who attended 16 general practices for methadone maintenance treatment and (2) administering structured questionnaires to both patients (n = 106) and general practitioners (GPs) (n = 15).
RESULTS: Clinical records indicated that 24 patients (19%) were screened for problem alcohol use in the 12 months prior to data collection, with problem alcohol use identified in 14 (58% of those screened, 11% of the full sample). Of those who had positive screening results for problem alcohol use, five received a brief intervention by a GP and none were referred to specialist treatment. Scores on the Alcohol Use Disorders Identification Test (AUDIT) revealed the prevalence of hazardous, harmful, and dependent drinking to be 25% (n = 26), 6% (n = 6), and 16% (n = 17), respectively. The intraclass correlation coefficient (ICC) for the proportion of patients with negative AUDITs was 0.038 (SE = 0.01). The ICCs for screening, brief intervention, and/or referral to treatment (SBIRT) were 0.16 (SE = 0.014), -0.06 (SE = 0.017), and 0.22 (SE = 0.026), respectively. Only 12 (11.3%) AUDIT questionnaires concurred with corresponding clinical records that a patient had any/no problem alcohol use. Regular use of primary care was evident, as 25% had visited their GP more than 12 times during the past 3 months.
CONCLUSIONS: Comparing clinical records with patients' experience of SBIRT can shed light on the process of care. Alcohol screening in people who attend primary care for substance use treatment is not routinely conducted. Interventions that enhance the care of problem alcohol use among this high-risk group are a priority.

Entities:  

Keywords:  SBIRT; agonist treatment; alcohol; family medicine; implementation; methadone; opioids

Mesh:

Substances:

Year:  2015        PMID: 25985200     DOI: 10.1080/15504263.2015.1027630

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  4 in total

1.  Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.

Authors:  Jan Klimas; Christopher Fairgrieve; Helen Tobin; Catherine-Anne Field; Clodagh Sm O'Gorman; Liam G Glynn; Eamon Keenan; Jean Saunders; Gerard Bury; Colum Dunne; Walter Cullen
Journal:  Cochrane Database Syst Rev       Date:  2018-12-05

2.  Feasibility of alcohol screening among patients receiving opioid treatment in primary care.

Authors:  Anne Marie Henihan; Geoff McCombe; Jan Klimas; Davina Swan; Dorothy Leahy; Rolande Anderson; Gerard Bury; Colum P Dunne; Eamon Keenan; John S Lambert; David Meagher; Clodagh O'Gorman; Tom P O'Toole; Jean Saunders; Gillian W Shorter; Bobby P Smyth; Eileen Kaner; Walter Cullen
Journal:  BMC Fam Pract       Date:  2016-11-05       Impact factor: 2.497

Review 3.  Alcohol use in opioid agonist treatment.

Authors:  Seonaid Nolan; Jan Klimas; Evan Wood
Journal:  Addict Sci Clin Pract       Date:  2016-12-08

4.  Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

Authors:  Geoff McCombe; Davina Swan; Eileen O'Connor; Gordana Avramovic; Peter Vickerman; Zoe Ward; Julian Surey; Juan Macías; John S Lambert; Walter Cullen
Journal:  JMIR Res Protoc       Date:  2018-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.